How to Manage: Type 2 diabetes

Current international guidelines for type 2 diabetes management include the use of two new classes of medication: sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists, in people with established kidney disease, heart disease or heart failure or with high cardiovascular risk. Rinki Murphy, associate professor of medicine at the University of Auckland and an endocrinologist specialising in diabetes and obesity, reviews how to utilise the benefits of these medications, including how to start them in this patient population, alongside usual management strategies for type 2 diabetes